INS and type 2 diabetes mellitus: Basal insulins, most of which are administered once daily, are generally preferred over fast-acting insulin analogues in individuals with type 2 diabetes, as they lead to similar glycaemic control with a much lower risk of hypoglycaemia and higher patient satisfaction [10].